- Virginia AG Jason Miyares, along with a bipartisan coalition of eight other AGs, announced a $720 million settlement with eight opioid drug manufacturers to resolve allegations that they contributed to the opioid epidemic.
- According to the press release, under the terms of the settlement, seven companies are barred from promoting or marketing opioids, restricted from selling products containing more than 40 mg of oxycodone per pill, and are required to implement systems for monitoring and reporting suspicious orders. The eighth company must halt manufacturing and sales of opioid products for 10 years, but may continue marketing and selling medications used to treat opioid use disorder.
- We have previously reported on ongoing AG efforts to address the opioid crisis, including a multistate settlement in principle with Mylan; a $7.4 billion multistate settlement with members of the Sackler family and Purdue Pharma, Inc.; a lawsuit by Kentucky AG Russell Coleman against a major supermarket; a settlement between Alaska AG Treg Taylor and CVS; and two multistate settlements totaling $500 million with Publicis Health, LLC, and Hikma Pharmaceuticals.